FARMACY FORLIFE

LIVE

Serial Number

97662145

Owner

Styles, David

Attorney

Zak Shusterman

Filing Date

Nov 3, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

FARMACY FORLIFE Trademark

Serial Number: 97662145 • Registration: 7846863

FARMACY FORLIFE is a trademark filed by Styles, David on November 3, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Styles, David (13 trademarks)

832 Scarsdale Ave
Scarsdale, NY 10583

Entity Type: 01

Legal Representation

Attorney of Record

Zak Shusterman

41 trademarks filed View all →

Correspondence Address

Zak Shusterman Law Office of Zak Shusterman

PO Box 131

Tarrytown, NY 10591

United States

Trademark Details

Filing Date

November 3, 2022

Registration Date

July 1, 2025

Published for Opposition

May 13, 2025

Goods & Services

Vitamins; Vitamin oils for human consumption; Vitamin supplements; Vitamins and vitamin preparations; Liquid herbal supplements; Natural herbal supplements

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 1, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Jul 1, 2025 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 13, 2025 NPUB

PUBLISHED FOR OPPOSITION

May 13, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 7, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 9, 2025 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 20, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 20, 2025 CRFA

NOTICE OF REVIVAL - E-MAILED

Feb 19, 2025 NREV

PETITION GRANTED - RESPONSE RECEIVED

Feb 19, 2025 PGRR

ASSIGNED TO PETITION STAFF

Feb 18, 2025 APET

TEAS PETITION TO REVIVE RECEIVED

Jan 10, 2025 PROA

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Nov 15, 2024 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Nov 15, 2024 ABN2

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

Aug 1, 2024 GNS1

SUBSEQUENT FINAL EMAILED

Aug 1, 2024 GNSF

SUBSEQUENT FINAL REFUSAL WRITTEN

Aug 1, 2024 CFRC

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 31, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 31, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 31, 2024 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 4, 2024 GNRN

NON-FINAL ACTION E-MAILED

Jun 4, 2024 GNRT

NON-FINAL ACTION WRITTEN

Jun 4, 2024 CNRT

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jun 4, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jun 4, 2024 XELR

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 6, 2024 GNFN

FINAL REFUSAL E-MAILED

Mar 6, 2024 GNFR

FINAL REFUSAL WRITTEN

Mar 6, 2024 CNFR

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 7, 2024 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 7, 2024 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 7, 2024 REAP

NOTICE OF REVIVAL - E-MAILED

Dec 28, 2023 NREV

NOTICE OF REVIVAL - E-MAILED

Dec 28, 2023 NREV

PETITION TO REVIVE-GRANTED

Dec 28, 2023 PETG

TEAS PETITION TO REVIVE RECEIVED

Dec 28, 2023 PROA

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Dec 8, 2023 MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Dec 8, 2023 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Dec 8, 2023 ABN2

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 24, 2023 GNRN

NON-FINAL ACTION E-MAILED

Aug 24, 2023 GNRT

NON-FINAL ACTION WRITTEN

Aug 24, 2023 CNRT

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 24, 2023 GNRN

NON-FINAL ACTION E-MAILED

Aug 24, 2023 GNRT

NON-FINAL ACTION WRITTEN

Aug 24, 2023 CNRT

ASSIGNED TO EXAMINER

Aug 17, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 22, 2022 NWOS

NEW APPLICATION ENTERED

Nov 7, 2022 NWAP

Related Trademarks

More from this Owner

MOTS MORAL OF THE STORY

FARMA CARES

More in Same Class

TME PHARMA